Advanced Cancer Therapeutics (ACT)
The James Graham Brown Cancer Center’s strategic plan calls for the development of strong translational research, primarily focused on drug discovery and development. We have one of the most robust pipelines of anti-cancer drugs of any cancer center in the nation. To ensure that these drugs are developed quickly, we have created Advanced Cancer Therapeutics (ACT). ACT will fund the development of two to three new drugs per year through Phase I clinical trials. The James Graham Brown Cancer Center is poised to make significant contributions to cancer treatment and prevention in Kentucky and throughout the world.